Lupus eritematoso asociado a eritema multiforme: Síndrome de Rowell. Reporte del primer caso en Chile
Author
dc.contributor.author
Heredia, Loreto
Author
dc.contributor.author
Arellano Lorca, Javier
Author
dc.contributor.author
Corredoira Salum, Yamile
Admission date
dc.date.accessioned
2021-08-24T22:46:10Z
Available date
dc.date.available
2021-08-24T22:46:10Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Rev. Med. Chile 2020; 148: 1690-1693
es_ES
Identifier
dc.identifier.issn
0034-9887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/181510
Abstract
dc.description.abstract
Rowell's syndrome is characterized by an association of lupus erythematosus and erythema multiforme, with distinctive laboratory findings. Its treatment is similar to lupus. We report a 16-year-old female presenting with skin lesions, laboratory and histology consistent with this entity. Because of the spread of cutaneous involvement and development of epidermal detachment, she required therapy with intravenous corticosteroids and gamma globulin.
es_ES
Abstract
dc.description.abstract
El síndrome de Rowell se caracteriza por una asociación de lupus eritematoso
y eritema multiforme, con hallazgos de laboratorio distintivos. Su tratamiento es
similar al lupus. Presentamos una mujer de 16 años que presenta lesiones cutáneas,
laboratorio e histología compatibles con esta entidad. Debido a la propagación de
afectación cutánea y desarrollo de desprendimiento epidérmico, requirió
terapia con corticosteroides intravenosos y gammaglobulina
Anti-cardiolipin antibodies have been recently described in patients with systemic lupus erythematosus and other autoimmune disorders. Venous and arterial thrombosis, thrombocytopenia and recurrent abortion have been ...